Auteur P. S. WANG

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Delay of first treatment of mental and substance use disorders in Mexico

G. BORGES ; P. S. WANG ; M. E. MEDINA-MORA ; LARA C. ; CHIU W. T. | 2007
Dans American Journal of Public Health (Vol.97 n°9, 2007) Article : Périodique

ENGLISH : OBJECTIVES: We studied failure and delay in making initial treatment contact after the first onset of a mental or substance use disorder in Mexico as a first step to understanding barriers to providing effective treatment in Mexico. [...]

Plus d'info

Ajouter à la sélection

Risk of death in elderly users of conventional vs. atypical antipsychotic medications

P. S. WANG ; SCHNEEWEISS S. ; J. AVORN ; M. A. FISCHER ; MOGUN H. ; SOLOMON D. H. ; BROOKHART M. A. | 2005
Dans New England Journal of Medicine (Vol.353, n°22, December 1, 2005) Article : Périodique

Background: Recently, the Food and Drug Administration (FDA) issued an advisory stating that atypical antipsychotic medications increase mortality among elderly patients. However, the advisory did not apply to conventional antipsychotic medicati[...]

Plus d'info

Ajouter à la sélection

Lien externe

Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication

P. S. WANG ; M. LANE ; M. OLFSON ; H. A. PINCUS ; K. B. WELLS ; R. C. KESSLER | 2005
Périodique

BACKGROUND: Dramatic changes have occurred in mental health treatments during the past decade. Data on recent treatment patterns are needed to estimate the unmet need for services. OBJECTIVE: To provide data on patterns and predictors of 12-mont[...]

Plus d'info

Ajouter à la sélection